< Back to previous page


Pyrazinamide resistance in Mycobacterium tuberculosis fails to bite?

Journal Contribution - Journal Article

In contrast to most other antimycobacterial drugs where--particularly in multidrug-resistant (MDR) strains--a limited number of resistance mutations dominate, pyrazinamide (PZA) resistance associated mutations remain highly diverse with limited clustering. This apparent lack of evolutionary selection for successful PZA resistance mechanisms deserves attention. A clear understanding of the epidemiology of PZA resistance acquisition and spread would be expected to result in important insights into how PZA might be better exploited in treatment regimens to minimize the amplification of Mycobacterium tuberculosis (MTB) drug resistance. We propose that PZA resistance typically induces a fitness cost that impairs MTB transmission. This would explain the lack of extensive clustering for PZA-resistant mutants. Our hypothesis also leads to a series of testable predictions which we outline that could confirm or refute our ideas.

Journal: Foodborne Pathogens and Disease
ISSN: 1535-3141
Issue: 6
Volume: 73
Pages: ftv037
Publication year:2015
Keywords:Antitubercular Agents/pharmacology, Disease Transmission, Infectious, Drug Resistance, Bacterial, Humans, Mycobacterium tuberculosis/drug effects, Pyrazinamide/pharmacology, Tuberculosis/microbiology, Virulence